ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Fate of Endogenous Alloreactive B Cells in Transplant Tolerance.

    J. Chen,1 J. Yang,1 A. Akl,1 Q. Wang,1 D. Yin,1 R. Sciammas,2 A. Chong.1

    1Transplant Surgery, University of Chicago, Chicago, IL; 2Methodist Research Institute, Methodist Medical Center, Houston, TX.

    The conceptual underpinning of our studies is that robust tolerance requires multiple mechanisms to enforce functional quiescence of alloreactive T and B cells. While much…
  • 2016 American Transplant Congress

    Sphingosine 1-Phosphate (S1P) Receptors Differentially Regulate Murine and Human CD4 T Cell Migration Across Lymphatic Endothelium.

    Y. Xiong,1 C. Brinkman,1 K. Hippen,2 B. Blazar,2 J. Bromberg.1

    1University of Maryland, Baltimore; 2University of Minnesota, Minneapolis.

    S1P and S1PR1 are used by T cells to migrate from thymus across microvascular endothelium to the blood circulation, and across medullary lymphatic endothelium of…
  • 2016 American Transplant Congress

    Impact of Low Dose Tacrolimus with Everolimus Regimen on Renal Pathology and T-Regulatory Cells in Kidney Transplant.

    A. Shetty,1 T. Opas,1 J. Mathew,1 V. Mas,2 J. Leventhal,1 N. Sustento-Reodica,1 L. Gallon.1

    1Northwestern University, Feinberg School of Medicine, Chicago, IL; 2University of Virginia, Charlottesville, VA.

    Calcineurin inhibitors (CNI) serve as the cornerstone of immunosuppression (IS) after kidney transplant. However chronic CNI nephrotoxicity has been implicated in allograft dysfunction. We hypothesize…
  • 2016 American Transplant Congress

    Pre-Listing Prescription Narcotic Use: Survival Implications in Liver Transplantation.

    H. Randall,1,6 K. Lentine,6 D. Segev,2,1 H. Yuan,6 J. Tuttle-Newhall,3 M. Nazzal,6 C. Varma,6 G. Hess,5 B. Kasiske,1 M. Schnitzler.6,1

    1Scientific Registry of Transplant Recipients, Minneapolis; 2Johns Hopkins, Baltimore; 3Dartmouth, Hanover; 4East Carolina Univ, Greenville; 5Symphony Health, Pittsburgh; 6Saint Louis Univ, St. Louis.

    Narcotic use among liver transplant (LTX) candidates is common. However, the survival implications and intensity of use are not well understood.We integrated national SRTR data…
  • 2016 American Transplant Congress

    SLPI in the Perfusion Liquid: A Predictor Marker of Short and Long Term Clinical Outcomes.

    A. Dotta,1 F. Caro,2 K. Peña Ponce,1 N. Ambrosi,2 J. Salaberry,2 X. García,1 E. Minué,1 L. León,1 F. Sánchez,2 F. Togniolo,1 C. Incardona,3 E. Chuluyan,2 D. Casadei.1

    1Instituto de Nefrología, Caba, Argentina; 2CEFYBO-UBA, Caba, Argentina; 3Fundación GADOR, Caba, Argentina.

    A lot of efforts have been done to identify the risk factors that tend to diminish the incidence of delayed graft function (DGF). Recently, the…
  • 2016 American Transplant Congress

    A Sustained Viral Response Achieved with Sofosbuvir/Ledipasvir May Increase the Incidence of Acute Cellular Rejection Post Liver Transplantation.

    K. Bortecen, R. Layman, B. Gelb, A. Winnick, G. Morgan, H. Tobias, L. Teperman.

    Transplant Surgery, New York University Langone Medical Center, New York, NY.

    Acute cellular rejection following liver transplantation has decreased in incidence with the use of potent immunosuppressive agents, affecting less than 25 percent of liver transplantation…
  • 2016 American Transplant Congress

    Smoking Exposure Among Kidney Allograft Recipients and Outcomes After Transplant.

    H. Gillott,1 S. Tahir,1 F. Jackson-Spence,1 F. Evison,2 J. Nath,3 A. Sharif.3

    1Medical School, University of Birmingham, Birmingham, United Kingdom; 2Medical Informatics, Queen Elizabeth Hospital, Birmingham, United Kingdom; 3Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom.

    The causal effects of smoking on major comorbidity and mortality in the general population are well established. However, the influence of smoking exposure on kidney…
  • 2016 American Transplant Congress

    Kidney Transplantation in HIV Patients: Effect of Race on the Choice of Anti-Thymocyte Globulin Induction Immunosuppression.

    M. Casey, T. Aijaz, X. Wen, S. Rehman, A. Santos, E. Thomas, K. Andreoni, K. Womer.

    University of Florida, Gainesville, FL.

    Introduction: HIV positive status is a well-known risk factor for acute rejection (AR) in kidney transplant recipients (KTR). In the United States, the majority of…
  • 2016 American Transplant Congress

    Macrophage Specific Deletion of RhoA Impedes Macrophage Functions and Abrogates Chronic Rejection of Cardiac Allograft.

    Y. Liu, W. Chen, X. Li, R. Ghobrial, M. Kloc.

    Surgery, The Houston Methodist, Houston, TX.

    Objective. Chronic rejection of transplanted organs remains the main obstacle in the long-term success of organ transplantation. Chronic rejection occurs in 40-45% of recipients at…
  • 2016 American Transplant Congress

    Administration of IL-33 Before Allogeneic Stem Cell Transplantation Expands Recipient Treg That Prevent Graft- vs. Host Disease.

    B. Matta,1 D. Reichenbach,2 X. Zhang,1 B. Koehn,2 L. Mathews,1 C. Feser,2 M. Smith,2 Q. Liu,1 R. Zeiser,3 B. Blazar,2 H. Turnquist.1

    1Dept of Surgery and Starzl Transplant Inst, Univ of Pittsburgh Sch of Med, Pittsburgh, PA; 2Dept of Pediatrics, Univ of Minnesota, Minneapolis, MN; 3Univ Med Cntr Freiburg, Freiburgh, Germany.

    Background: During allogeneic hematopoietic cell transplantation (alloHCT), non-hematopoietic cell IL-33 is augmented and released by recipient conditioning to promote Type 1 alloimmunity and lethal acute…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences